SCHEMBL29336909

SCHEMBL29336909

CC(C)(CN1CCOCC1)S(=O)(=O)c1c[nH]c2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.46
ALDH1A1 P00352 6/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
GAA P10253 2/20 0.43
KDM4E B2RXH2 2/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2C19 P33261 1/20 0.42
AKT1 P31749 1/20 0.42
PIK3CA P42336 1/20 0.42
HRH3 Q9Y5N1 4/20 0.41
HTR6 P50406 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPT P10636 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
TACR2 P21452 1/20 0.40
PKM P14618 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29337125 0.76 CYP2D6 (0.51) CYP2D6ALDH1A1GAAHTR6KMT2A
SCHEMBL27249941 0.76 LMNA (0.47) ALDH1A1L3MBTL1GAAKDM4ELMNA
SCHEMBL29336734 0.75 CYP2D6 (0.48) CYP2D6ALDH1A1L3MBTL1GAAKDM4E
SCHEMBL29336975 0.72 ALDH1A1 (0.44) CYP2D6ALDH1A1GAAKDM4ELMNA
SCHEMBL29337104 0.71 ALDH1A1 (0.42) ALDH1A1L3MBTL1GAAKDM4ELMNA
SCHEMBL1856027 0.69 BCHE (0.79) CYP2D6ALDH1A1L3MBTL1GAAKDM4E
SCHEMBL29336695 0.68 OPRK1 (0.47) CYP2D6ALDH1A1L3MBTL1GAAKDM4E
SCHEMBL29992486 0.67 HTR2A (0.76) CYP2D6HRH3HTR6TACR2
SCHEMBL29338313 0.67 ALDH1A1 (0.40) CYP2D6ALDH1A1L3MBTL1GAAKDM4E
SCHEMBL734052 0.67 HTR2A (0.76) CYP2D6HRH3HTR6TACR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF Université de Montréal (CA) 2024-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240239801-A1 PYRIMIDO[5,4,D]PYRIMIDINE COMPOUNDS, COMPOSITIONS COMPRISING THEM AND USES THEREOF NRAS, BRAF, KRAS CYP2D6 658/4885ALDH1A1 1786/4885L3MBTL1 2913/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.